Harbor Investment Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
3,433
+1,059
| +45% | +$73.1K | 0.02% | 344 |
|
|
2025
Q1 | $165K | Buy |
2,374
+574
| +32% | +$39.9K | 0.02% | 392 |
|
|
2024
Q4 | $155K | Buy |
1,800
+153
| +9% | +$13.2K | 0.01% | 382 |
|
|
2024
Q3 | $196K | Sell |
1,647
-247
| -13% | -$29.4K | 0.02% | 343 |
|
|
2024
Q2 | $270K | Buy |
1,894
+36
| +2% | +$5.14K | 0.03% | 297 |
|
|
2024
Q1 | $239K | Buy |
1,858
+977
| +111% | +$125K | 0.02% | 315 |
|
|
2023
Q4 | $91.1K | Buy |
881
+653
| +286% | +$67.6K | 0.01% | 438 |
|
|
2023
Q3 | $20.7K | Buy |
228
+20
| +10% | +$1.82K | ﹤0.01% | 687 |
|
|
2023
Q2 | $16.8K | Buy |
208
+4
| +2% | +$324 | ﹤0.01% | 923 |
|
|
2023
Q1 | $16.2K | Hold |
204
| – | – | ﹤0.01% | 946 |
|
|
2022
Q4 | $13.8K | Buy |
204
+8
| +4% | +$541 | ﹤0.01% | 969 |
|
|
2022
Q3 | $10K | Buy |
196
+8
| +4% | +$408 | ﹤0.01% | 1040 |
|
|
2022
Q2 | $10K | Sell |
188
-340
| -64% | -$18.1K | ﹤0.01% | 1030 |
|
|
2022
Q1 | $29K | Hold |
528
| – | – | ﹤0.01% | 872 |
|
|
2021
Q4 | $30K | Hold |
528
| – | – | ﹤0.01% | 866 |
|
|
2021
Q3 | $25K | Hold |
528
| – | – | ﹤0.01% | 912 |
|
|
2021
Q2 | $22K | Hold |
528
| – | – | ﹤0.01% | 884 |
|
|
2021
Q1 | $18K | Hold |
528
| – | – | ﹤0.01% | 890 |
|
|
2020
Q4 | $18K | Hold |
528
| – | – | ﹤0.01% | 839 |
|
|
2020
Q3 | $18K | Hold |
528
| – | – | ﹤0.01% | 756 |
|
|
2020
Q2 | $17K | Buy |
528
+386
| +272% | +$12.4K | ﹤0.01% | 672 |
|
|
2020
Q1 | $4K | Hold |
142
| – | – | ﹤0.01% | 874 |
|
|
2019
Q4 | $4K | Buy |
+142
| New | +$4K | ﹤0.01% | 725 |
|